glp-1 options for type 2 diabetes and obesity 2025 What is the pipeline future medications for obesity? The metabolic health revolution has

Always follow the manufacturer's recommended titration schedule in the SmPC, and consider extending the time at lower doses if patients experience significant gastrointestinal symptoms

Learn why most patients shouldnt be denied ketogenic therapy over unfounded cardiac concerns and how to navigate outliers like lean-mass hyper-responders

Why rapid loss triggers more shedding The body does not distinguish between intentional caloric restriction and starvation

For comprehensive resources and the latest research, visit Diabetes in Control

Study Finds GLP-1 Drugs Like Ozempic and Wegovy Not Linked to Pancreatic Cancer Study Finds GLP-1 Drugs Like Ozempic and Wegovy Not Linked to Pancreatic Cancer Recent research findings indicate that drugs belonging to the GLP-1RA class do not pose an increased risk of pancreatic cancer